Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 2536 in Advanced Pancreatic Cancer
NCT00710710Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BI-2536 in pancreatic ductal adenocarcinoma (PDAC), sponsored by Boehringer Ingelheim. Started Aug 2006; status: completed.
02
Drugs
BI-2536
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00710710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710710.